Jobs at GenVec | Ladders

Why work for us

GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company working to build a pipeline of therapeutics and vaccines based on its adenovector technology platform that can realize the promise of gene-based medicine. The companys lead product candidate for hearing loss and balance disorders, partnered with Novartis, is in a first-in-man gene delivery Phase 1/2 clinical trial in patients with severe to profound hearing loss. GenVec therapeutics and vaccines have been administered to over 3,000 clinical study subjects.

Snapshot

Employees: 15
Market Cap: $13.5 million
Revenue: $1 million
5 Year Trend: -50.81 %
Net Income: $-5.7 million
Jobs at GenVec
There are no jobs at the current time